BMI BADGER METER INC
AI brief AI-written, not reviewed by a person
Latest figures show year-end 2025 results: revenue 916,663,000 USD, net income 141,634,000 USD, operating income 183,421,000 USD, and operating cash flow 183,698,000 USD; stockholders’ equity at 713,294,000 USD as of 2025-12-31, with total assets 973,577,000 USD and total liabilities from 2012 to 2015 not comparable to current period. For the latest quarter, the most recent available shows 3Q2026 revenue 235,938,000 USD, net income 35,903,000 USD, operating income 47,742,000 USD, and cash flow from operations in the quarter of 33,893,000 USD. Diluted EPS guidance appears for long-term periods: 12 months to 2025-12-31 shows 4.79 USD per share; 12 months to 2024-12-31 shows 4.23 USD per share; diluted EPS for quarters in 2026 include 0.93–1.24 USD per share depending on the quarter.
- Revenue (year) for 12 months to 2025-12-31: 916,663,000 USD vs 826,558,000 USD for 12 months to 2024-12-31. [1]
- Net income (year) for 12 months to 2025-12-31: 141,634,000 USD vs 124,942,000 USD for 12 months to 2024-12-31. [1]
- Operating income (year) for 12 months to 2025-12-31: 183,421,000 USD vs 157,936,000 USD for 12 months to 2024-12-31. [1]
- Operating cash flow (year) for 12 months to 2025-12-31: 183,698,000 USD vs 155,034,000 USD for 12 months to 2024-12-31. [1]
- Stockholders’ equity at 2026-09-30: 651,132,000 USD; at 2026-06-30: 682,880,000 USD; at 2026-03-31: 690,431,000 USD; at 2025-12-31: 713,294,000 USD; at 2025-09-30: 702,510,000 USD. [1]
- Revenue (quarter) for 3 months to 2026-09-30: 235,938,000 USD; 3 months to 2025-12-31: 220,706,000 USD. [1]
- Net income (quarter) for 3 months to 2026-09-30: 35,903,000 USD; 3 months to 2025-12-31: 33,575,000 USD. [1]
- Diluted EPS (year) 12 months to 2025-12-31: 4.79 USD/shares; 12 months to 2024-12-31: 4.23 USD/shares. [1]
- 3 months to 2026-03-31 operating cash flow: 33,893,000 USD; 3 months to 2025-12-31: 33,575,000 USD. [1][2]
- Total assets (as of various dates around 2026): 943,648,000 USD (2026-09-30), 998,169,000 USD (2026-06-30), 970,808,000 USD (2026-03-31). [1]
- Shares outstanding: 28,563,652 as of 2026-10-09; 28,986,847 as of 2026-07-10; 29,185,570 as of 2026-04-08; 29,181,598 as of 2026-02-10; 29,469,785 as of 2025-10-13. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
What the sources did not support
- No consolidated quarterly figures beyond the provided 3Q2026 and 4Q2025 data for all metrics; some items (e.g., total liabilities) are from a historical 2012 filing and not directly comparable to current period figures.
- No explicit cash equivalents breakdown or reconciliation; some figures are quarterly without a full fiscal-year context.
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-09-30) | 235,938,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2025-12-31) | 916,663,000 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-09-30) | 35,903,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-12-31) | 141,634,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-09-30) | 47,742,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2025-12-31) | 183,421,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-09-30) | 1.24 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-12-31) | 4.79 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-03-31) | 33,893,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-12-31) | 183,698,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-09-30) | 943,648,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2012-01-31) | 16,754,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-09-30) | 651,132,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2022-03-31) | 89,219,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-09) | 28,563,652 shares | sec-companyfacts | current |
Context
No reviewed context has been published for BMI. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add BMI to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: BMI.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.